Patient-Focused Drug Development and Real World Study

Area of Science:

• Medical research methodology
• Clinical trial design
• Drug development

Background:

• Patient-focused drug development (PFDD) is crucial for advancing medicine.
• Both PFDD and real-world studies (RWS) are gaining significant interest due to their unique advantages.
• Optimizing clinical research design and implementation is a key goal.

Purpose of the Study:

• To innovate research methods in drug development.
• To optimize the design and implementation of clinical research.
• To explore the potential of a "patient-focused RWS" research model.

Main Methods:

• Comparative analysis of PFDD and RWS clinical trials.
• Evaluation of PICO elements, research teams, and data acquisition.
• Assessment of the feasibility and significance of integrating PFDD and RWS.

Main Results:

• PFDD prioritizes patient needs, willingness, and satisfaction, collecting patient experience data.
• RWS emphasizes research environment facticity and broad patient sources, addressing extrapolation and applicability.
• Both PFDD and RWS ultimately benefit patients through their respective focuses.

Conclusions:

• Integrating PFDD concepts with RWS methods maximizes patient benefits.
• A combined PFDD-RWS model can facilitate drug development and dissemination.
• This approach offers innovative research methods applicable across various fields.